523 related articles for article (PubMed ID: 11197250)
1. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.
García-Samaniego J; Rodríguez M; Berenguer J; Rodríguez-Rosado R; Carbó J; Asensi V; Soriano V
Am J Gastroenterol; 2001 Jan; 96(1):179-83. PubMed ID: 11197250
[TBL] [Abstract][Full Text] [Related]
2. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.
Bräu N; Fox RK; Xiao P; Marks K; Naqvi Z; Taylor LE; Trikha A; Sherman M; Sulkowski MS; Dieterich DT; Rigsby MO; Wright TL; Hernandez MD; Jain MK; Khatri GK; Sterling RK; Bonacini M; Martyn CA; Aytaman A; Llovet JM; Brown ST; Bini EJ;
J Hepatol; 2007 Oct; 47(4):527-37. PubMed ID: 17692986
[TBL] [Abstract][Full Text] [Related]
3. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
[TBL] [Abstract][Full Text] [Related]
4. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
5. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
[TBL] [Abstract][Full Text] [Related]
6. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB
Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414
[TBL] [Abstract][Full Text] [Related]
7. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
8. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
11. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
[TBL] [Abstract][Full Text] [Related]
13. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis.
Aizawa Y; Shibamoto Y; Takagi I; Zeniya M; Toda G
Cancer; 2000 Jul; 89(1):53-9. PubMed ID: 10897000
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management.
Verucchi G; Calza L; Manfredi R; Chiodo F
Infection; 2004 Feb; 32(1):33-46. PubMed ID: 15007741
[TBL] [Abstract][Full Text] [Related]
15. Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.
Hamada H; Yatsuhashi H; Yano K; Daikoku M; Arisawa K; Inoue O; Koga M; Nakata K; Eguchi K; Yano M
Cancer; 2002 Jul; 95(2):331-9. PubMed ID: 12124834
[TBL] [Abstract][Full Text] [Related]
16. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma and hepatitis C in Mexico.
Mondragón-Sánchez R; Garduño-López AL; Hernández-Castillo E; Gómez-Gómez E; Ruiz-Molina JM
Hepatogastroenterology; 2005; 52(64):1159-62. PubMed ID: 16001652
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
Dohmen K; Shigematsu H; Irie K; Ishibashi H
Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
[TBL] [Abstract][Full Text] [Related]
19. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection.
Jacobson IM; Davis GL; El-Serag H; Negro F; Trépo C
Clin Gastroenterol Hepatol; 2010 Nov; 8(11):924-33; quiz e117. PubMed ID: 20713178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]